search
Back to results

A Non-inferiority Trial on Pain Relief During Oocyte Retrieval

Primary Purpose

Infertility

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
fentanyl
pethidine
Diazepam
Midazolam
Sponsored by
Kwong Wah Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Infertility focused on measuring fentanyl, midazolam, pethidine, diazepam

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • presence of both ovaries;
  • body mass index less than 30
  • written informed consent and
  • Chinese

Exclusion Criteria:

  • IVF cycle converted from ovulation induction or intrauterine insemination cycles;
  • patient requests general anaesthesia for TUGOR;
  • history of drug sensitivity to lignocaine/fentanyl/midazolam/diazepam/pethidine;
  • less than 3 dominant follicles present;
  • dominant follicles present in one ovary only and
  • TUGOR performed on one side only.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Placebo Comparator

    Placebo Comparator

    Arm Label

    A: intravenous fentanyl, midazolam

    B: intravenous pethidine, diazepam

    Arm Description

    group A will be given intravenous 0.1mg fentanyl and 5mg midazolam prior oocyte retrieval

    group B will be given intravenous 25mg pethidine, 5mg diazepam prior oocyte retrieval

    Outcomes

    Primary Outcome Measures

    Pain Level During Oocyte Retrieval
    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful
    Pain Level After Oocyte Retrieval
    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful

    Secondary Outcome Measures

    Percentage of Participants With Side Effects by Type
    side effects will be scored by yes or no
    Patient's Satisfaction on Oocyte Retrieval
    satisfaction will be scored from 0-3 (0=excellent, 1=satisfactory, 2=fair, 3=unsatisfactory)
    Clinical Pregnancy Rate
    presence of intrauterine sac in ultrasound after a positive pregnancy test
    Ongoing Pregnancy Rate
    positive fetal heart pulsation seen in ultrasound at eight weeks of gestation
    Patient's Satisfaction on Pain Relief
    satisfaction on pain relief will be scored at 0-10 (10 being most satisfied)
    Sedation Level
    S = sleeping, easily aroused; 1 = awake and alert; 2 = occasionally drowsy, easy to arouse; 3 = frequently drowsy, arousable, drifts off to sleep during conversation; 4 = somnolent, minimal or no response to stimuli

    Full Information

    First Posted
    June 17, 2015
    Last Updated
    February 11, 2019
    Sponsor
    Kwong Wah Hospital
    Collaborators
    The University of Hong Kong, Queen Mary Hospital, Hong Kong
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02494180
    Brief Title
    A Non-inferiority Trial on Pain Relief During Oocyte Retrieval
    Official Title
    A Prospective, Non-inferiority Randomized Double-blinded Trial Comparing Fentanyl and Midazolam vs Diazepam and Pethidine for Pain Relief During Oocyte Retrieval
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2016 (Actual)
    Primary Completion Date
    February 2018 (Actual)
    Study Completion Date
    February 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Kwong Wah Hospital
    Collaborators
    The University of Hong Kong, Queen Mary Hospital, Hong Kong

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The objective of the trial is to compare fentanyl and midazolam vs diazepam and pethidine in terms of the pain levels and post-operative side effects of TUGOR
    Detailed Description
    In-vitro fertilization / embryo transfer (IVF / ET) is a well-established method to treat various causes of infertility. It involves multiple follicular development, retrieval of oocytes and embryo transfer after fertilization. Egg retrieval at the majority of IVF units is performed through the transvaginal route under ultrasound guidance (TUGOR) [1]. During TUGOR, the needle has to pass through the mucosa in the vaginal vault in order to puncture the follicles in the ovary. The procedures are generally short, lasting about 20-30 minutes but are still painful without anaesthesia or analgesia. Intravenous sedation with or without local anaesthesia is the most widely used method. Conscious sedation is a safe and cost-effective method of providing analgesia and anesthesia for TUGOR. [2] It is easy to administer in cooperative and motivated patients. It has a relatively low risk for adverse effects on oocyte and embryo quality and pregnancy rates. [3] Paracervical block (PCB) in conjunction with conscious sedation during TUGOR was shown to significantly reduce the pain during TUGOR when compared to PCB alone [4]. A Cochrane review on various methods of sedation and analgesia for pain relief during TUGOR has shown no single method or delivery system appeared superior for pregnancy rates and pain relief. [5] Most of the methods seemed to work well and the effect was usually enhanced by addition of another method such as pain relief with paracervical block. [6] The investigators' reproductive centre has recently aligned with the Assisted Reproduction Centre of the University of Hong Kong (HKU). The investigators are using 0.1mg fentanyl and 5mg midazolam intravenously for pain relief in TUGOR at Kwong Wah Hospital (KWH) whereas 5mg diazepam and 25mg pethidine intravenously are being used in HKU. The investigators would like to compare fentanyl and midazolam vs diazepam and pethidine in terms of pain levels and post-operative side effects of TUGOR in this prospective non-inferiority randomized double-blinded trial. The investigators postulate there are no differences in the pain levels between two groups but the postoperative side effects may be different.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Infertility
    Keywords
    fentanyl, midazolam, pethidine, diazepam

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    170 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    A: intravenous fentanyl, midazolam
    Arm Type
    Placebo Comparator
    Arm Description
    group A will be given intravenous 0.1mg fentanyl and 5mg midazolam prior oocyte retrieval
    Arm Title
    B: intravenous pethidine, diazepam
    Arm Type
    Placebo Comparator
    Arm Description
    group B will be given intravenous 25mg pethidine, 5mg diazepam prior oocyte retrieval
    Intervention Type
    Drug
    Intervention Name(s)
    fentanyl
    Intervention Description
    arm A receiving iv fentanyl
    Intervention Type
    Drug
    Intervention Name(s)
    pethidine
    Intervention Description
    arm B receiving iv pethidine
    Intervention Type
    Drug
    Intervention Name(s)
    Diazepam
    Other Intervention Name(s)
    valium
    Intervention Description
    arm B receiving iv diazepam
    Intervention Type
    Drug
    Intervention Name(s)
    Midazolam
    Other Intervention Name(s)
    dormicum
    Intervention Description
    arm A receiving iv midazolam
    Primary Outcome Measure Information:
    Title
    Pain Level During Oocyte Retrieval
    Description
    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful
    Time Frame
    will be assessed within 4 hours of oocyte retrieval
    Title
    Pain Level After Oocyte Retrieval
    Description
    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful
    Time Frame
    will be assessed within 4 hours of oocyte retrieval
    Secondary Outcome Measure Information:
    Title
    Percentage of Participants With Side Effects by Type
    Description
    side effects will be scored by yes or no
    Time Frame
    will be assessed within 4 hours of oocyte retrieval
    Title
    Patient's Satisfaction on Oocyte Retrieval
    Description
    satisfaction will be scored from 0-3 (0=excellent, 1=satisfactory, 2=fair, 3=unsatisfactory)
    Time Frame
    will be assessed within 4 hours of oocyte retrieval
    Title
    Clinical Pregnancy Rate
    Description
    presence of intrauterine sac in ultrasound after a positive pregnancy test
    Time Frame
    will be assessed within ten weeks of oocyte retrieval
    Title
    Ongoing Pregnancy Rate
    Description
    positive fetal heart pulsation seen in ultrasound at eight weeks of gestation
    Time Frame
    will be assessed within ten weeks of oocyte retrieval
    Title
    Patient's Satisfaction on Pain Relief
    Description
    satisfaction on pain relief will be scored at 0-10 (10 being most satisfied)
    Time Frame
    within 4 hours after retrieval
    Title
    Sedation Level
    Description
    S = sleeping, easily aroused; 1 = awake and alert; 2 = occasionally drowsy, easy to arouse; 3 = frequently drowsy, arousable, drifts off to sleep during conversation; 4 = somnolent, minimal or no response to stimuli
    Time Frame
    immediately after retrieval

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    40 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: presence of both ovaries; body mass index less than 30 written informed consent and Chinese Exclusion Criteria: IVF cycle converted from ovulation induction or intrauterine insemination cycles; patient requests general anaesthesia for TUGOR; history of drug sensitivity to lignocaine/fentanyl/midazolam/diazepam/pethidine; less than 3 dominant follicles present; dominant follicles present in one ovary only and TUGOR performed on one side only.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Shui Fan Lai
    Organizational Affiliation
    Kwong Wah Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    A Non-inferiority Trial on Pain Relief During Oocyte Retrieval

    We'll reach out to this number within 24 hrs